152 related articles for article (PubMed ID: 26000477)
1. Alike but Different: RAF Paralogs and Their Signaling Outputs.
Desideri E; Cavallo AL; Baccarini M
Cell; 2015 May; 161(5):967-970. PubMed ID: 26000477
[TBL] [Abstract][Full Text] [Related]
2. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
Kiel C; Serrano L
Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
[TBL] [Abstract][Full Text] [Related]
3. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
4. Second nature: biological functions of the Raf-1 "kinase".
Baccarini M
FEBS Lett; 2005 Jun; 579(15):3271-7. PubMed ID: 15943972
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
Pan MR; Chang HC; Hung WC
Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
[TBL] [Abstract][Full Text] [Related]
7. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
8. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
9. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
[TBL] [Abstract][Full Text] [Related]
10. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.
Dwivedi Y; Rizavi HS; Conley RR; Pandey GN
Mol Psychiatry; 2006 Jan; 11(1):86-98. PubMed ID: 16172610
[TBL] [Abstract][Full Text] [Related]
11. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins.
Shi H; Zhang T; Yi Y; Ma Y
Oncol Rep; 2016 Jun; 35(6):3593-9. PubMed ID: 27004682
[TBL] [Abstract][Full Text] [Related]
13. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.
Kumar P; Coltas IK; Kumar B; Chepeha DB; Bradford CR; Polverini PJ
Cancer Res; 2007 Feb; 67(3):1193-202. PubMed ID: 17283155
[TBL] [Abstract][Full Text] [Related]
15. Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.
Mei M; Su B; Harrison K; Chao M; Siedlak SL; Previll LA; Jackson L; Cai DX; Zhu X
J Neurochem; 2006 Dec; 99(5):1377-88. PubMed ID: 17064357
[TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein regulation of raf and MAPK signaling.
Hagan S; Garcia R; Dhillon A; Kolch W
Methods Enzymol; 2006; 407():248-59. PubMed ID: 16757329
[TBL] [Abstract][Full Text] [Related]
17. Raf kinases in cancer-roles and therapeutic opportunities.
Maurer G; Tarkowski B; Baccarini M
Oncogene; 2011 Aug; 30(32):3477-88. PubMed ID: 21577205
[TBL] [Abstract][Full Text] [Related]
18. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
19. Synergistic binding of the phosphorylated S233- and S259-binding sites of C-RAF to one 14-3-3ζ dimer.
Molzan M; Ottmann C
J Mol Biol; 2012 Nov; 423(4):486-95. PubMed ID: 22922483
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]